Cargando…
Properdin Levels in Human Sepsis
Properdin is a normal serum protein that increases the production of complement activation products by binding C3b integral to convertase complexes and amplifying their activity at the site of activation. Thereby, it not only can aid in the resolution of infection but also contribute to tissue damag...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313716/ https://www.ncbi.nlm.nih.gov/pubmed/25699043 http://dx.doi.org/10.3389/fimmu.2015.00024 |
_version_ | 1782355267389751296 |
---|---|
author | Stover, Cordula M. McDonald, John Byrne, Simon Lambert, David G. Thompson, Jonathan P. |
author_facet | Stover, Cordula M. McDonald, John Byrne, Simon Lambert, David G. Thompson, Jonathan P. |
author_sort | Stover, Cordula M. |
collection | PubMed |
description | Properdin is a normal serum protein that increases the production of complement activation products by binding C3b integral to convertase complexes and amplifying their activity at the site of activation. Thereby, it not only can aid in the resolution of infection but also contribute to tissue damage. In human sepsis, circulating complement C3 concentrations are decreased, though C3 is described as a positive acute phase reactant. However, properdin levels in human sepsis have not been reported. In this study, serum from 81 critically ill patients (predominately abdominal and respiratory sepsis) were analyzed for properdin levels at defined points of their stay in the intensive care unit (ICU) and compared with 61 age and sex-matched healthy volunteers. Properdin concentrations were significantly decreased in patients with sepsis on admission to ICU, but increased after clinical recovery to exceed levels observed in healthy volunteers. Properdin concentrations at ICU admission were decreased in non-survivors of sepsis compared to survivors, but this did not correlate with APACHE II score. However, pathologically low properdin levels (<7 μg/ml) were related to increased duration of treatment. |
format | Online Article Text |
id | pubmed-4313716 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-43137162015-02-19 Properdin Levels in Human Sepsis Stover, Cordula M. McDonald, John Byrne, Simon Lambert, David G. Thompson, Jonathan P. Front Immunol Immunology Properdin is a normal serum protein that increases the production of complement activation products by binding C3b integral to convertase complexes and amplifying their activity at the site of activation. Thereby, it not only can aid in the resolution of infection but also contribute to tissue damage. In human sepsis, circulating complement C3 concentrations are decreased, though C3 is described as a positive acute phase reactant. However, properdin levels in human sepsis have not been reported. In this study, serum from 81 critically ill patients (predominately abdominal and respiratory sepsis) were analyzed for properdin levels at defined points of their stay in the intensive care unit (ICU) and compared with 61 age and sex-matched healthy volunteers. Properdin concentrations were significantly decreased in patients with sepsis on admission to ICU, but increased after clinical recovery to exceed levels observed in healthy volunteers. Properdin concentrations at ICU admission were decreased in non-survivors of sepsis compared to survivors, but this did not correlate with APACHE II score. However, pathologically low properdin levels (<7 μg/ml) were related to increased duration of treatment. Frontiers Media S.A. 2015-02-02 /pmc/articles/PMC4313716/ /pubmed/25699043 http://dx.doi.org/10.3389/fimmu.2015.00024 Text en Copyright © 2015 Stover, McDonald, Byrne, Lambert and Thompson. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Stover, Cordula M. McDonald, John Byrne, Simon Lambert, David G. Thompson, Jonathan P. Properdin Levels in Human Sepsis |
title | Properdin Levels in Human Sepsis |
title_full | Properdin Levels in Human Sepsis |
title_fullStr | Properdin Levels in Human Sepsis |
title_full_unstemmed | Properdin Levels in Human Sepsis |
title_short | Properdin Levels in Human Sepsis |
title_sort | properdin levels in human sepsis |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4313716/ https://www.ncbi.nlm.nih.gov/pubmed/25699043 http://dx.doi.org/10.3389/fimmu.2015.00024 |
work_keys_str_mv | AT stovercordulam properdinlevelsinhumansepsis AT mcdonaldjohn properdinlevelsinhumansepsis AT byrnesimon properdinlevelsinhumansepsis AT lambertdavidg properdinlevelsinhumansepsis AT thompsonjonathanp properdinlevelsinhumansepsis |